MicroRNA-155 in oral squamous cell carcinoma: Overexpression, localization, and prognostic potential

Head and Neck

Volumn 37, Issue 7, 2015, Pages 970-976

  Shi, Lin Jun ^a   Zhang, Chen Yang ^a   Zhou, Zeng Tong ^a   Ma, Jing Yuan ^a   Liu, Yang ^a   Bao, Zhe Xuan ^a   Jiang, Wei Wen ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

fluorescence in situ hybridization; microRNA 155; oral squamous cell carcinoma; polymerase chain reaction (PCR); prognosis

Indexed keywords

LOCKED NUCLEIC ACID; MICRORNA 155; MICRORNA; MIRN155 MICRORNA, HUMAN;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CLINICAL ARTICLE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; MALE; MICROARRAY ANALYSIS; MOUTH SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; VASCULAR ENDOTHELIUM; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; MOUTH TUMOR; PATHOLOGY; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MICROARRAY ANALYSIS; MICRORNAS; MIDDLE AGED; MOUTH NEOPLASMS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84931574239     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.23700     Document Type: Article

References (36)

1. International Agency for Research on Cancer. Globocan 2008: Cancer incidence and mortality worldwide database; 2008. Available at: http://www.iarc.fr/en/media-centre/iarcnews/2010/globocan2008.php. Accessed February 25, 2014.
2. Jung DW, Che ZM, Kim J, et al., Tumor-stromal crosstalk in invasion of oral squamous cell carcinoma: a pivotal role of CCL7. Int J Cancer 2010; 127: 332-344.
3. Krol J, Loedige I, Filipowicz W,. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 2010; 11: 597-610.
4. Ryan BM, Robles AI, Harris CC,. Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer 2010; 10: 389-402.
5. Calin GA, Croce CM,. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6: 857-866.
6. Metzler M, Wilda M, Busch K, Viehmann S, Borkhardt A,. High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma. Genes Chromosomes Cancer 2004; 39: 167-169.
7. Clurman BE, Hayward WS,. Multiple proto-oncogene activations in avian leukosis virus-induced lymphomas: evidence for stage-specific events. Mol Cell Biol 1989; 9: 2657-2664.
8. Tam W, Ben-Yehuda D, Hayward WS,. bic, a novel gene activated by proviral insertions in avian leukosis virus-induced lymphomas, is likely to function through its noncoding RNA. Mol Cell Biol 1997; 17: 1490-1502.
9. Eis PS, Tam W, Sun L, et al., Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci U S A 2005; 102: 3627-3632.
10. Costinean S, Sandhu SK, Pedersen IM, et al., Src homology 2 domain-containing inositol-5-phosphatase and CCAAT enhancer-binding protein beta are targeted by miR-155 in B cells of Emicro-MiR-155 transgenic mice. Blood 2009; 114: 1374-1382.
11. Jiang S, Zhang HW, Lu MH, et al., MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene. Cancer Res 2010; 70: 3119-3127.
12. Wang B, Majumder S, Nuovo G, et al., Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice. Hepatology 2009; 50: 1152-1161.
13. Raponi M, Dossey L, Jatkoe T, et al., MicroRNA classifiers for predicting prognosis of squamous cell lung cancer. Cancer Res 2009; 69: 5776-5783.
14. Gironella M, Seux M, Xie MJ, et al., Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development. Proc Natl Acad Sci U S A 2007; 104: 16170-16175.
15. Nikiforova MN, Tseng GC, Steward D, Diorio D, Nikiforov YE,. MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility. J Clin Endocrinol Metab 2008; 93: 1600-1608.
16. Wang X, Tang S, Le SY, et al., Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS One 2008; 3: e2557.
17. Yanaihara N, Caplen N, Bowman E, et al., Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006; 9: 189-198.
18. Saito M, Schetter AJ, Mollerup S, et al., The association of microRNA expression with prognosis and progression in early-stage, non-small cell lung adenocarcinoma: a retrospective analysis of three cohorts. Clin Cancer Res 2011; 17: 1875-1882.
19. Greither T, Grochola LF, Udelnow A, Lautenschläger C, Würl P, Taubert H,. Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival. Int J Cancer 2010; 126: 73-80.
20. Shibuya H, Iinuma H, Shimada R, Horiuchi A, Watanabe T,. Clinicopathological and prognostic value of microRNA-21 and microRNA-155 in colorectal cancer. Oncology 2010; 79: 313-320.
21. Hui AB, Lenarduzzi M, Krushel T, et al., Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas. Clin Cancer Res 2010; 16: 1129-1139.
22. Chang SS, Jiang WW, Smith I, et al., MicroRNA alterations in head and neck squamous cell carcinoma. Int J Cancer 2008; 123: 2791-2797.
23. Chen HC, Chen GH, Chen YH, et al., MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma. Br J Cancer 2009; 100: 1002-1011.
24. Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP, Wei WI,. Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin Cancer Res 2008; 14: 2588-2592.
25. Ramdas L, Giri U, Ashorn CL, et al., miRNA expression profiles in head and neck squamous cell carcinoma and adjacent normal tissue. Head Neck 2009; 31: 642-654.
26. Du ZM, Hu LF, Wang HY, et al., Upregulation of MiR-155 in nasopharyngeal carcinoma is partly driven by LMP1 and LMP2A and downregulates a negative prognostic marker JMJD1A. PLoS One 2011; 6: e19137.
27. Sobin L, Wittekind C,. International Union Against Cancer (UICC): TNM Classification of Malignant Tumours. 6th ed. New York, NY: Wiley-Liss; 2002.
28. Silahtaroglu AN, Nolting D, Dyrskjøt L, et al., Detection of microRNAs in frozen tissue sections by fluorescence in situ hybridization using locked nucleic acid probes and tyramide signal amplification. Nat Protoc 2007; 2: 2520-2528.
29. Habbe N, Koorstra JB, Mendell JT, et al., MicroRNA miR-155 is a biomarker of early pancreatic neoplasia. Cancer Biol Ther 2009; 8: 340-346.
30. Rather MI, Nagashri MN, Swamy SS, Gopinath KS, Kumar A,. Oncogenic microRNA-155 down-regulates tumor suppressor CDC73 and promotes oral squamous cell carcinoma cell proliferation: implications for cancer therapeutics. J Biol Chem 2013; 288: 608-618.
31. Hiyoshi Y, Kamohara H, Karashima R, et al., MicroRNA-21 regulates the proliferation and invasion in esophageal squamous cell carcinoma. Clin Cancer Res 2009; 15: 1915-1922.
32. Tili E, Croce CM, Michaille JJ,. miR-155: on the crosstalk between inflammation and cancer. Int Rev Immunol 2009; 28: 264-284.
33. Aggarwal BB, Vijayalekshmi RV, Sung B,. Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe. Clin Cancer Res 2009; 15: 425-430.
34. Martin MM, Buckenberger JA, Jiang J, et al., The human angiotensin II type 1 receptor +1166 A/C polymorphism attenuates microRNA-155 binding. J Biol Chem 2007; 282: 24262-24269.
35. Zhang H, Li W, Nan F, et al., MicroRNA expression profile of colon cancer stem-like cells in HT29 adenocarcinoma cell line. Biochem Biophys Res Commun 2011; 404: 273-278.
36. Tan L, Sui X, Deng H, Ding M,. Holoclone forming cells from pancreatic cancer cells enrich tumor initiating cells and represent a novel model for study of cancer stem cells. PLoS One 2011; 6: e23383.